Insulin dose calculator app for type 1 diabetes in children
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new insulin dose calculator app for children under 12 with type 1 diabetes who use daily insulin shots and already count carbs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is younger than 12 years old
- Diagnosed with type 1 diabetes for more than 1 year
- Uses multiple daily insulin injections (not a pump)
- Has been counting carbohydrates for at least 1 month
- Has not used an insulin dose calculator (like an app) in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone-based educational tool that uses artificial intelligence to help parents learn how to count carbohydrates for their child with type 1 diabetes. It aims to see if the app is practical and helpful for improving insulin dosing decisions.
This study compares two ways of estimating meal size for people with type 1 diabetes who use automated insulin delivery systems. One method is detailed carb counting, the other is a simpler, qualitative estimate of meal size. The goal is to see which approach works better for managing blood sugar.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a mobile app that provides structured education to help teenagers with type 1 diabetes improve their blood sugar control, confidence, and daily self-care habits.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.